Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Insights into the genetic basis of type 2 diabetes.

Kato N.

J Diabetes Investig. 2013 May 6;4(3):233-44. doi: 10.1111/jdi.12067. Review.

2.

The end or the start of understanding the genetics of type 2 diabetes.

Chuang LM.

J Diabetes Investig. 2010 Oct 19;1(5):159-60. doi: 10.1111/j.2040-1124.2010.00042.x. No abstract available.

3.

Genetic determinants of cardiometabolic risk: a proposed model for phenotype association and interaction.

Blackett PR, Sanghera DK.

J Clin Lipidol. 2013 Jan-Feb;7(1):65-81. doi: 10.1016/j.jacl.2012.04.079. Epub 2012 Apr 22. Review.

4.

Genetic risk factors for type 2 diabetes: a trans-regulatory genetic architecture?

Elbein SC, Gamazon ER, Das SK, Rasouli N, Kern PA, Cox NJ.

Am J Hum Genet. 2012 Sep 7;91(3):466-77. doi: 10.1016/j.ajhg.2012.08.002.

5.

Next generation analytic tools for large scale genetic epidemiology studies of complex diseases.

Mechanic LE, Chen HS, Amos CI, Chatterjee N, Cox NJ, Divi RL, Fan R, Harris EL, Jacobs K, Kraft P, Leal SM, McAllister K, Moore JH, Paltoo DN, Province MA, Ramos EM, Ritchie MD, Roeder K, Schaid DJ, Stephens M, Thomas DC, Weinberg CR, Witte JS, Zhang S, Zöllner S, Feuer EJ, Gillanders EM.

Genet Epidemiol. 2012 Jan;36(1):22-35. doi: 10.1002/gepi.20652. Epub 2011 Dec 6.

6.

T2DM: Why Epigenetics?

Fradin D, Bougnères P.

J Nutr Metab. 2011;2011:647514. doi: 10.1155/2011/647514. Epub 2011 Nov 3.

7.

IRS1 gene variants, dysglycaemic metabolic changes and type-2 diabetes risk.

Yiannakouris N, Cooper JA, Shah S, Drenos F, Ireland HA, Stephens JW, Li KW, Elkeles R, Godsland IF, Kivimaki M, Hingorani AD, Kumari M, Talmud PJ, Humphries SE.

Nutr Metab Cardiovasc Dis. 2012 Dec;22(12):1024-30. doi: 10.1016/j.numecd.2011.05.009. Epub 2011 Sep 14.

8.

Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN study.

Irvin MR, Wineinger NE, Rice TK, Pajewski NM, Kabagambe EK, Gu CC, Pankow J, North KE, Wilk JB, Freedman BI, Franceschini N, Broeckel U, Tiwari HK, Arnett DK.

PLoS One. 2011;6(8):e24052. doi: 10.1371/journal.pone.0024052. Epub 2011 Aug 25.

9.

Lay perceptions of predictive testing for diabetes based on DNA test results versus family history assessment: a focus group study.

Wijdenes-Pijl M, Dondorp WJ, Timmermans DR, Cornel MC, Henneman L.

BMC Public Health. 2011 Jul 5;11:535. doi: 10.1186/1471-2458-11-535.

10.

Mitochondrial DNA backgrounds might modulate diabetes complications rather than T2DM as a whole.

Achilli A, Olivieri A, Pala M, Hooshiar Kashani B, Carossa V, Perego UA, Gandini F, Santoro A, Battaglia V, Grugni V, Lancioni H, Sirolla C, Bonfigli AR, Cormio A, Boemi M, Testa I, Semino O, Ceriello A, Spazzafumo L, Gadaleta MN, Marra M, Testa R, Franceschi C, Torroni A.

PLoS One. 2011;6(6):e21029. doi: 10.1371/journal.pone.0021029. Epub 2011 Jun 9.

11.

Pleiotropy of type 2 diabetes with obesity.

Hasstedt SJ, Hanis CL, Das SK, Elbein SC.

J Hum Genet. 2011 Jul;56(7):491-5. doi: 10.1038/jhg.2011.46. Epub 2011 Apr 28.

12.
13.

Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci.

Stitzel ML, Sethupathy P, Pearson DS, Chines PS, Song L, Erdos MR, Welch R, Parker SC, Boyle AP, Scott LJ; NISC Comparative Sequencing Program, Margulies EH, Boehnke M, Furey TS, Crawford GE, Collins FS.

Cell Metab. 2010 Nov 3;12(5):443-55. doi: 10.1016/j.cmet.2010.09.012. Erratum in: Cell Metab. 2010 Dec 1;12(6):683.

14.

Building genetic scores to predict risk of complex diseases in humans: is it possible?

Liu S, Song Y.

Diabetes. 2010 Nov;59(11):2729-31. doi: 10.2337/db10-1081. No abstract available.

Supplemental Content

Support Center